Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Platelet activation in myocardial ischemic syndromes.

Gurbel PA, Bliden KP, Hayes KM, Tantry U.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):535-45. Review.

PMID:
15225113
2.

[Platelet activation in acute coronary syndrome and interventional therapy].

Bigalke B, Lindemann S, Gawaz M.

Hamostaseologie. 2007 Dec;27(5):338-43. German.

PMID:
18060243
4.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India.

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
5.

Role of platelets in the pathophysiology of acute coronary syndrome.

Massberg S, Schulz C, Gawaz M.

Semin Vasc Med. 2003 May;3(2):147-62. Review.

PMID:
15199478
6.

The clinical significance of platelet membrane glycoproteins.

McEver RP.

Hematol Oncol Clin North Am. 1990 Feb;4(1):87-105. Review.

PMID:
2155906
7.

Thrombosis and thrombolysis: platelet membrane glycoproteins.

Skinner MP.

Heart Lung Circ. 2007 Jun;16(3):176-9. Epub 2007 Apr 18. Review.

PMID:
17446123
8.

[The role of platelets for the pathophysiology of acute coronary syndromes].

Langer H, Gawaz M.

Hamostaseologie. 2006 May;26(2):114-8. Review. German.

PMID:
16676053
9.

Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.

Perneby C, Wallén NH, Hofman-Bang C, Tornvall P, Ivert T, Li N, Hjemdahl P.

Thromb Haemost. 2007 Dec;98(6):1316-22.

PMID:
18064330
10.

von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.

Spiel AO, Gilbert JC, Jilma B.

Circulation. 2008 Mar 18;117(11):1449-59. doi: 10.1161/CIRCULATIONAHA.107.722827. Review.

11.

Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.

Małek ŁA, Spiewak M, Filipiak KJ, Grabowski M, Szpotańska M, Rosiak M, Główczyńska R, Imiela T, Huczek Z, Opolski G.

Kardiol Pol. 2007 Jan;65(1):40-5; discussion 46. English, Polish.

12.

The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention.

Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S.

Clin Cardiol. 2008 Mar;31(3 Suppl 1):I17-20. doi: 10.1002/clc.20363. Review. Erratum in: Clin Cardiol. 2009 Feb;32(2):111.

13.
14.

Relationship between age and platelet activation in patients with stable and unstable angina.

Gilstad JR, Gurbel PA, Andersen RE.

Arch Gerontol Geriatr. 2009 Mar-Apr;48(2):155-9. doi: 10.1016/j.archger.2007.12.006. Epub 2008 Feb 20.

PMID:
18282622
15.

Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.

Jennings LK.

Thromb Haemost. 2009 Aug;102(2):248-57. doi: 10.1160/TH09-03-0192. Review.

PMID:
19652875
16.

[Prostaglandins and ischemic cardiopathy].

Balsano F, Davì G, Violi F, Censi C.

G Ital Cardiol. 1992 Dec;22(12):1427-36. Review. Italian. No abstract available.

PMID:
1294428
17.
18.
20.

Platelet activation by extracellular matrix proteins in haemostasis and thrombosis.

Watson SP.

Curr Pharm Des. 2009;15(12):1358-72. Review.

PMID:
19355974

Supplemental Content

Support Center